LigoCyte Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1998-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.ligocyte.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Phase 1 Norwalk Vaccine Study
Phase 1
Completed
- Conditions
- Norovirus
- Interventions
- Drug: Adjuvant/ExcipientsBiological: Norwalk VLP VaccineDevice: placebo
- First Posted Date
- 2008-12-11
- Last Posted Date
- 2015-05-06
- Lead Sponsor
- LigoCyte Pharmaceuticals, Inc.
- Target Recruit Count
- 61
- Registration Number
- NCT00806962
- Locations
- 🇺🇸
University of Maryland Center for Vaccine Development, Baltimore, Maryland, United States
🇺🇸Saint Louis University, Saint Louis, Missouri, United States
🇺🇸University of Rochester Medical Center, Rochester, New York, United States
News
No news found